SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-019182
Filing Date
2016-08-22
Accepted
2016-08-22 16:06:41
Documents
56
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imuc-63016x10q.htm 10-Q 509505
2 EXHIBIT 10.1 imuc-63016xexhibit101.htm EX-10.1 28070
3 EXHIBIT 31.1 imuc-63016xexhibit311.htm EX-31.1 13216
4 EXHIBIT 31.2 imuc-63016xexhibit312.htm EX-31.2 13284
5 EXHIBIT 32.1 imuc-63016xexhibit321.htm EX-32.1 6342
6 EXHIBIT 32..2 imuc-63016xexhibit322.htm EX-32..2 6357
  Complete submission text file 0001628280-16-019182.txt   3695945

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imuc-20160630.xml EX-101.INS 511668
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imuc-20160630.xsd EX-101.SCH 38087
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imuc-20160630_cal.xml EX-101.CAL 48508
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imuc-20160630_def.xml EX-101.DEF 162492
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imuc-20160630_lab.xml EX-101.LAB 504632
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imuc-20160630_pre.xml EX-101.PRE 286449
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35560 | Film No.: 161845368
SIC: 2834 Pharmaceutical Preparations